These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10354383)

  • 1. A home blood transfusion programme for beta-thalassaemia patients.
    Madgwick KV; Yardumian A
    Transfus Med; 1999 Jun; 9(2):135-8. PubMed ID: 10354383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood transfusion in beta thalassaemia major.
    Rebulla P
    Transfus Med; 1995 Dec; 5(4):247-58. PubMed ID: 8646287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red Cell Alloimmunization In Multitransfused Thalassaemia Major Patients.
    Moeen S; Farooq N; Irshad R; Ashfaq M; Farooq U; Idris M
    J Ayub Med Coll Abbottabad; 2018; 30(1):81-84. PubMed ID: 29504337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Iron Chelating Agents in Transfusion Dependent Thalassaemia Major Patients.
    Santra S; Bhattacharya A; Mukhopadhyay T; Agrawal D; Kumar S; Das P; Chakrabarty P
    Mymensingh Med J; 2015 Oct; 24(4):838-44. PubMed ID: 26620028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial burden of beta-thalassaemia major in Antalya, south Turkey.
    Canatan D; Ratip S; Kaptan S; Cosan R
    Soc Sci Med; 2003 Feb; 56(4):815-9. PubMed ID: 12560014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron overload is associated with low anti-müllerian hormone in women with transfusion-dependent β-thalassaemia.
    Chang HH; Chen MJ; Lu MY; Chern JP; Lu CY; Yang YL; Jou ST; Lin DT; Yang YS; Lin KH
    BJOG; 2011 Jun; 118(7):825-31. PubMed ID: 21401854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major.
    Cazzola M; De Stefano P; Ponchio L; Locatelli F; Beguin Y; Dessi C; Barella S; Cao A; Galanello R
    Br J Haematol; 1995 Mar; 89(3):473-8. PubMed ID: 7734344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major.
    Prati D
    Vox Sang; 2000; 79(3):129-37. PubMed ID: 11111230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a transfusion preparation of newly formed red cells and standard washed red cell transfusions in patients with homozygous beta-thalassemia.
    Collins AF; Gonçalves-Dias C; Haddad S; Talbot R; Herst R; Tyler BJ; Zuber E; Blanchette VS; Olivieri NF
    Transfusion; 1994 Jun; 34(6):517-20. PubMed ID: 8023393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of red blood cell alloimmunization in transfusion-dependent β-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review.
    Al-Riyami AZ; Al-Muqbali A; Al-Sudiri S; Murthi Panchatcharam S; Zacharia M; Al-Mahrooqi S; Al-Hosni S; Al-Marhoobi A; Daar S
    Transfusion; 2018 Apr; 58(4):871-878. PubMed ID: 29399805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A time-driven, activity-based costing methodology for determining the costs of red blood cell transfusion in patients with beta thalassaemia major.
    Burns KE; Haysom HE; Higgins AM; Waters N; Tahiri R; Rushford K; Dunstan T; Saxby K; Kaplan Z; Chunilal S; McQuilten ZK; Wood EM
    Transfus Med; 2019 Feb; 29(1):33-40. PubMed ID: 29637650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal insufficiency is prevalent in HbE/β-thalassaemia paediatric patients irrespective of their clinical severity and transfusion requirement.
    Nakavachara P; Viprakasit V
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):776-83. PubMed ID: 23634994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.
    Thompson AA; Walters MC; Kwiatkowski J; Rasko JEJ; Ribeil JA; Hongeng S; Magrin E; Schiller GJ; Payen E; Semeraro M; Moshous D; Lefrere F; Puy H; Bourget P; Magnani A; Caccavelli L; Diana JS; Suarez F; Monpoux F; Brousse V; Poirot C; Brouzes C; Meritet JF; Pondarré C; Beuzard Y; Chrétien S; Lefebvre T; Teachey DT; Anurathapan U; Ho PJ; von Kalle C; Kletzel M; Vichinsky E; Soni S; Veres G; Negre O; Ross RW; Davidson D; Petrusich A; Sandler L; Asmal M; Hermine O; De Montalembert M; Hacein-Bey-Abina S; Blanche S; Leboulch P; Cavazzana M
    N Engl J Med; 2018 Apr; 378(16):1479-1493. PubMed ID: 29669226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion.
    Trinchero A; Marchetti M; Giaccherini C; Tartari CJ; Russo L; Falanga A
    Blood Transfus; 2017 Sep; 15(5):413-421. PubMed ID: 27723451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health related quality of life among children with transfusion dependent β-thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study.
    Mettananda S; Pathiraja H; Peiris R; Bandara D; de Silva U; Mettananda C; Premawardhena A
    Health Qual Life Outcomes; 2019 Aug; 17(1):137. PubMed ID: 31395066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-β thalassaemia.
    Biswas S; Nag A; Ghosh K; Ray R; Roy K; Bandyopadhyay A; Bhattacharyya M
    Ann Hematol; 2019 Feb; 98(2):289-299. PubMed ID: 30413899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion therapy and alloimmunization in Thalassemia Intermedia: a 10 year experience at a tertiary care university hospital.
    Al-Riyami AZ; Al-Mahrooqi S; Al-Hinai S; Al-Hosni S; Al-Madhani A; Daar S
    Transfus Apher Sci; 2014 Aug; 51(1):42-6. PubMed ID: 24816438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hb E beta +-thalassaemia in west Malaysia: clinical features in the most common beta-thalassaemia mutation of the Malays [IVS 1-5 (G-->C)].
    George E; Wong HB
    Singapore Med J; 1993 Dec; 34(6):500-3. PubMed ID: 8153710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurse practitioner support for transfusion in patients with haematological disorders in hospital and at home.
    Craig JI; Milligan P; Cairns J; McClelland DB; Parker AC
    Transfus Med; 1999 Mar; 9(1):31-6. PubMed ID: 10216903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.